SCHEMBL6929561

SCHEMBL6929561

Cn1c(CCl)nc2cnccc2c1=O

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.43
KDM4E B2RXH2 1/20 0.41
ALOX15 P16050 1/20 0.41
TSHR P16473 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
IDO1 P14902 4/20 0.41
KDM4C Q9H3R0 5/20 0.40
LATS1 O95835 3/20 0.40
LATS2 Q9NRM7 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
LMNA P02545 1/20 0.39
PDE10A Q9Y233 2/20 0.39
EIF4EBP1 Q13541 1/20 0.39
CDK1 P06493 1/20 0.39
CCNB1 P14635 1/20 0.39
CCNE1 P24864 1/20 0.39
CDK2 P24941 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6927584 0.88 HDAC6 (0.43) HDAC6KDM4EALOX15TSHRTDP1
SCHEMBL29571733 0.80 HDAC6 (0.64) HDAC6KDM4EALOX15TSHRTDP1
SCHEMBL1161498 0.80 HDAC6 (0.64) HDAC6KDM4EALOX15TSHRTDP1
SCHEMBL31330665 0.78 IDO1 (0.48) KDM4EIDO1KDM4CLATS1
SCHEMBL2045483 0.75 ALDH1A1 (0.46) HDAC6KDM4EALOX15TSHRTDP1
SCHEMBL13789540 0.73 L3MBTL1 (0.61) TSHRL3MBTL1IDO1LMNA
SCHEMBL1161537 0.72 CYP3A4 (0.55) HDAC6KDM4EALOX15TSHRTDP1
SCHEMBL14473822 0.72 HIF1A (0.57) TSHRL3MBTL1IDO1KDM4CLMNA
SCHEMBL6930783 0.71 PDE4A (0.49) HDAC6KDM4EALOX15TSHRTDP1
SCHEMBL3321587 0.71 ALDH1A1 (0.49) KDM4ETDP1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 WO disclosed